Condition
Chronic Pain Due to Malignancy (Finding)
Total Trials
3
Recruiting
0
Active
0
Completed
2
Success Rate
66.7%-20% vs avg
Key Insights
Highlights
Success Rate
67% trial completion
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 54/100
Termination Rate
33.3%
1 terminated out of 3 trials
Success Rate
66.7%
-19.8% vs benchmark
Late-Stage Pipeline
33%
1 trials in Phase 3/4
Results Transparency
50%
1 of 2 completed with results
Key Signals
1 with results67% success
Data Visualizations
Phase Distribution
3Total
Not Applicable (1)
P 2 (1)
P 3 (1)
Trial Status
Completed2
Terminated1
Trial Success Rate
66.7%
Benchmark: 86.5%
Based on 2 completed trials
Clinical Trials (3)
Showing 3 of 3 trials
NCT03847311Phase 2Completed
Sulfasalazine in Decreasing Opioids Requirements in Breast Cancer Patients
NCT03339622Phase 3Terminated
Safety and Efficacy of Smoked Cannabis for Improving Quality of Life in Advanced Cancer Patients
NCT03119896Not ApplicableCompleted
Supporting Self-management of Chronic Pain
Showing all 3 trials